BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23351963)

  • 1. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
    Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
    Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
    Okura T; Higuchi K; Kitamura A; Deguchi Y
    Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
    Higuchi K; Kitamura A; Okura T; Deguchi Y
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
    Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
    J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
    Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
    Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
    Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
    J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
    Kitamura A; Higuchi K; Kurosawa T; Okura T; Kubo Y; Deguchi Y
    Biol Pharm Bull; 2022; 45(10):1585-1589. PubMed ID: 36184519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
    Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
    Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
    Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
    J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.
    Doetsch DA; Ansari S; Jensen O; Gebauer L; Dücker C; Brockmöller J; Sachkova A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
    Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
    Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mystery of the human proton-organic cation antiporter: One transport protein or many?
    Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
    Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
    Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
    Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport characteristics of tramadol in the blood-brain barrier.
    Kitamura A; Higuchi K; Okura T; Deguchi Y
    J Pharm Sci; 2014 Oct; 103(10):3335-41. PubMed ID: 25175482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB).
    Sekhar GN; Georgian AR; Sanderson L; Vizcay-Barrena G; Brown RC; Muresan P; Fleck RA; Thomas SA
    PLoS One; 2017; 12(3):e0173474. PubMed ID: 28362799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood-Brain Barrier.
    Kurosawa T; Tega Y; Uchida Y; Higuchi K; Tabata H; Sumiyoshi T; Kubo Y; Terasaki T; Deguchi Y
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress of pyrilamine-sensitive H~+/OC antiporter].
    Wang XY; Zhang ZR
    Yao Xue Xue Bao; 2016 Jun; 51(6):886-91. PubMed ID: 29878742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.
    Chapy H; Smirnova M; André P; Schlatter J; Chiadmi F; Couraud PO; Scherrmann JM; Declèves X; Cisternino S
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
    Okura T; Kato S; Deguchi Y
    Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrilamine-sensitive proton-coupled organic cation (H
    Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
    J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.